Fetal serum β2-microglobulin and cystatin C in the prediction of post-natal renal function in bilateral hypoplasia and hyperechogenic enlarged kidneys

Prenatal Diagnosis

Volumn 24, Issue 5, 2004, Pages 327-332

  Muller, Françoise ^a   Dreux, Sophie ^b   Audibert, François ^b   Chabaud, Jean Jacques ^b   Rousseau, Thierry ^b   D'Hervé, Dominique ^b   Dumez, Yves ^b   Ngo, Sandrine ^b   Gubler, Marie Claire ^b   Dommergues, Marc ^b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b NONE

Author keywords

Fetal blood; Fetal renal function; Fetal serum 2 microglobulin; Fetal serum cystatin C; Prenatal diagnosis

Indexed keywords

BETA 2 MICROGLOBULIN; CYSTATIN C; CYSTATIN;

ARTICLE; CONTROLLED STUDY; FETUS; FETUS ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; KIDNEY HYPOPLASIA; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; NEWBORN; POSTNATAL CARE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; BLOOD; CLINICAL TRIAL; EVALUATION; FEMALE; FETUS BLOOD; FRANCE; KIDNEY FUNCTION TEST; MEDICAL RECORD; METABOLISM; MULTICENTER STUDY; PREDICTION AND FORECASTING; PREGNANCY; PRENATAL DEVELOPMENT;

BETA 2-MICROGLOBULIN; CYSTATINS; FEMALE; FETAL BLOOD; FRANCE; HUMANS; INFANT, NEWBORN; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MEDICAL RECORDS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES;

EID: 2642528039     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.866     Document Type: Article

References (37)

1. Ariyurek Y, Leeuwen IL, Spruit L, Ravine D, Breuning MH, Petters DJ. 2004. Large deletions in polycystic kidney disease 1 (PKD1) gene. Hum Mutat 23: 99.
2. Berry SM, Lecolier B, Smith RS, et al. 1995. Predictive value of serum β2-microglobulin for neonatal renal function. Lancet 345: 1277-1278.
3. Blickman JG, Bramson RT, Herrin JT. 1995. Autosomal recessive polycystic kidney disease: long-term sonographic findings in patients surviving the neonatal period. Am J Roentgenol 164: 1247-1250.
4. Bökenkamp A, Dieterich C, Dressler F, et al. 2001. Fetal serum concentrations of cystatin C and β2-microglobulin as predictors of postnatal kidney function. Am J Obstet Gynecol 185: 468-475.
5. Carr MC, Benacerraf BR, Estroff JA, Mandell J. 1995. Prenatally diagnosed bilateral hyperechoic kidneys with normal amniotic fluid: postnatal outcome. The Journal of Urology 153: 442-444.
6. Chamberlain PF, Manning FA, Morrison I, et al. 1984. Ultrasound evaluation of amniotic fluid volume. I. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome. Am J Obstet Gynecol 150: 245-249.
7. Chitty LS, Clark T, Maxwell D. 1998. Perlman syndrome-a cause of enlarged, hyperechogenic kidneys. Prenat Diagn 18: 1163-1168.
8. Cobet G, Gummelt T, Bollmann R, et al. 1996. Assessment of serum levels of a-1-microglobulin, β-2-microglobulin, and retinol binding protein in the fetal blood. A method for prenatal evaluation of renal function. Prenat Diagn 16: 299-305.
9. Dalton M, Romero R, Grannum P, et al. 1985. Antenatal diagnosis of renal anomalies with ultrasound. IV. Bilateral multicystic kidney disease. Am J Obstet Gynecol 151: 38-49.
10. Dommergues M, Muller F, Ngo S, et al. 2000. Fetal serum β2-microglobulin predicts postnatal renal function in bilateral uropathies. Kidney International 58: 312-316.
11. Donkerwolke RA, Sander PC, Van Steckelenburg GJ, et al. 1970. Serum creatinine values in healthy children. Acta Pediatr Scand 59: 399-402.
12. Estroff JA, Mandell J, Benacerraf BR. 1991. Increased renal parenchymal echogenicity in the fetus: importance and clinical outcome. Radiology 181: 135-139.
13. Eugène M, Muller F, Dommergues M, et al. 1994. Evaluation of postnatal renal function in fetuses with bilateral obstructive uropathies by proton nuclear magnetic resonance spectroscopy. Am J Obstet Gynecol 170: 595-602.
14. Fedman H, Guignard JP. 1982. Plasma creatinine in the first months of life. Arch Dis Child 57: 123-126.
15. Fick GM, Johnson AM, Strain JD, et al. 1993. Characteristics of very early onset autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3: 1863-1870.
16. Filler G, Priem F, Lepage N, et al. 2002. β-trace protein, cystatin C, β2-microglobulin and creatinine compared for detecting impaired glomerular filtration rates in children. Clin Chem 48: 729-736.
17. Filler G, Witt I, Priem F, et al. 1997. Are cystatin C and β2-microglobulin better markers than serum creatinine for prediction of a normal glomerular filtration rate in pediatric subjects?. Clin Chem 43: 1077-1078.
18. Freedman AL, Bukowski TP, Smith CA, et al. 1997. Use of urinary β-2-microglobulin to predict severe renal damage in fetal obstructive uropathy. Fetal Diagn Ther 12: 1-6.
19. Guay-Woodford LM, Galliani CA, Musulman-Mroczek E, et al. 1998. Diffuse renal cystic disease in children: morphologic and genetic correlations. Pediatr Nephrol 12: 173-182.
20. Howlett DC, Greenwood KL, Jarosz JM, et al. 1997. The incidence of transient renal medullary hyperechogenicity in neonatal ultrasound examination. Br J Radiol 70: 140-143.
21. Laterza OF, Price C, Scott MG. 2002. Cystatin C an improved estimator of glomerular filtration rate?. Clin Chem 48: 699-707.
22. Lazebnik N, Bellinger MF, Ferguson JE, et al. 1999. Insights into the pathogenesis and natural history of fetuses with Multicystic Dysplastic Kidney Disease. Prenat diagn 19: 418-423.
23. Le Guern H, Collet M, Jehannin B, Boog G. 1983. Le rein foetal, pathologie, sémiologie échographique et corrélations pré et postnatales. JEMU 4: 65-71.
24. Lipitz S, Ryan G, Samuell C, et al. 1993. Fetal urine analysis for the assessment of renal function in obstructive uropathy. Am J Obstet Gynecol 168: 174-179.
25. Muller F, Bernard MA, Benkirane A, et al. 1999. Fetal urine cystatin C as a predictor of postnatal renal function in bilateral uropathies. Clinical Chemistry 45: 2292-2293.
26. Muller F, Dommergues M, Mandelbrot L, et al. 1993. Fetal urine biochemistry predicts postnatal renal function in children with bilateral obstructive uropathies. Obstet Gynecol 82: 813-820.
27. Muller F, Dommergues M, Bussières L, et al. 1996. Development of human renal function: reference intervals for 10 biochemical markers in fetal urine. Clinical Chemistry 42: 1855-1860.
28. Newman DJ, Thakkar H, Edwards RG, et al. 1994. Serum cystatin C: a replacement for creatinine as a biochemical marker of GFR. Kidney Int 46(Suppl. 47): S20-S21.
29. Nicolini U, Fisk NM, Rodeck CH, Beacham J. 1992. Fetal urine biochemistry: an index of renal maturation and dysfunction. Br J Obstet Gynaecol 99: 46-50.
30. Nolte S, Mueller B, Pringsheim W. 1991. Serum alpha 1-microglobulin and β2-microglobulin for the estimation of fetal glomerular renal function. Pediatr Nephrol 5: 573-577.
31. Revillard JP, Vincent C. 1988. Structure and metabolism of β2-microglobulin. Contrib Nephrol 62: 44.
32. Romero R, Cullen M, Jeanty P, et al. 1984. The diagnosis of congenital renal anomalies with ultrasound. II. Infantile polycystic kidney disease. Am J Obstet Gynecol 150: 259-262.
33. Schardijn GHS, Van Eps Statius LW. 1987. β2-Microglobulin: its significance in the evaluation of renal function. Kidney Int 32: 635-641.
34. Stapleton FB, Hilton S, Wilcox J, Leopold GR. 1981. Transient nephromegaly simulating infantile polycystic disease of the kidneys. Pediatrics 67: 554-559.
35. Tassis BMG, Trespidi L, Tirelli A, et al. 1997. Serum β2-microglobulin in fetuses with urinary tract anomalies. Am J Obstet Gynecol 176: 54-57.
36. Tsatsaris V, Gagnadoux MF, Aubry MC, et al. 2002. Prenatal diagnosis of bilateral isolated fetal hyperechogenic kidneys. Is it possible to predict long term outcome? BJOG 109: 1388-1393.
37. Zerres K, Mücher G, Becker J, et al. 1998. Prenatal diagnosis of Autosomal Recessive Polycystic Kidney Disease (ARPKD): molecular genetics, clinical experience and fetal morphology. Am J Hum Genet 76: 137-144.